Email not displaying correctly?  View it in your browser.
Volume 5, Issue 4, December 2016

Director's message: Farewell 2016
Dr. Diasio recounts highlights from an exciting year at the Mayo Clinic Cancer Center.
Avoid routine double mastectomy when possible
Consensus group urges weighing pros, cons and patient preference in unilateral breast cancer.
Stereotactic radiosurgery is best for some brain tumors
Shift in practice may reserve whole-brain radiation for patients with more extensive disease.
Researchers identify unique breast microbiome
These findings may help identify potential causes of breast cancer and encourage new therapies.
More women eligible for Herceptin, benefit uncertain
Updated guidelines underscore need to identify the most optimal candidates for HER-2 directed therapy.
Drug combo safe for diffuse large B-cell lymphoma
Drugs targeting the P13K-mTOR pathway add benefit when combined with standard R-CHOP therapy.
Stool DNA test added to colorectal screening
Updated guidelines make noninvasive colorectal cancer screening option available to millions.
Meet the Investigator: Jamie N. Bakkum-Gamez, M.D.
Oncologist discusses her research, including developing a screening test for endometrial cancer.
We're interested in your feedback about this email.

Want the Print Edition?
A print edition of Forefront is published annually. To request a free subscription, send your name and mailing address to
Mayo Clinic Cancer Center
13400 E. Shea Blvd.
Scottsdale, AZ 85259

4500 San Pablo Road
Jacksonville, FL 32224

200 First Street SW
Rochester, MN 55905